Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices
Novo Nordisk's decision to end its partnership with Hims & Hers is driven by concerns over the safety of fake Wegovy drugs sold by the telehealth firm.
Debate rages over Alzheimer's drug lecanemab as UK limits approval
"The unusually long time that they have spent considering the drug suggests that this has not been an easy or straightforward decision," said psychiatrist Robert Howard at University College London in a statement to the UK Science Media Centre.